From the strategic update in March 2021.
Personally, I'm very interested to see if Bisantrene inhibits FTO in non-cancerous cells and how that effects the downstream expression of genes and the impact that has on cellular function, because there have been a couple non-cancerous diseases linked to overexpression of FTO. I don't know how much 'low-cost' is, but I believe the cost to reward ratio is worth taking a look at.
- Forums
- ASX - By Stock
- RAC
- Ann: Race Initiates Heart Safety Preclinical Study for Bisantrene
Ann: Race Initiates Heart Safety Preclinical Study for Bisantrene, page-36
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.50 |
Change
-0.020(1.32%) |
Mkt cap ! $258.9M |
Open | High | Low | Value | Volume |
$1.53 | $1.55 | $1.50 | $75.48K | 50.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12000 | $1.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.50 | 3500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12000 | 1.495 |
1 | 6000 | 1.490 |
1 | 950 | 1.485 |
1 | 650 | 1.480 |
1 | 946 | 1.475 |
Price($) | Vol. | No. |
---|---|---|
1.500 | 3500 | 1 |
1.505 | 79 | 1 |
1.515 | 406 | 1 |
1.520 | 5532 | 1 |
1.525 | 2987 | 4 |
Last trade - 12.36pm 20/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |